LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Trametinib
0.01
 69.32 771.67 3964 10212 0.3882 0.5514
MN20160304_L01
M14
MCF 10A-H2B-mCherry Trametinib
0.01
 71.54 771.67 3443 10532 0.3269 0.4868
MN20160304_L01
H06
MCF 10A-H2B-mCherry Trametinib
0.01
 71.54 771.67 4125 10532 0.3916 0.5598
MN20160304_L01
M14
MCF 10A-H2B-mCherry Trametinib
0.01
 73.76 771.67 3509 10851 0.3234 0.4875
MN20160304_L01
H06
MCF 10A-H2B-mCherry Trametinib
0.01
 73.76 771.67 4273 10851 0.3938 0.5664
MN20160304_L01
M14
MCF 10A-H2B-mCherry Trametinib
0.01
 76.02 771.67 3645 11106 0.3282 0.4971
MN20160304_L01
H06
MCF 10A-H2B-mCherry Trametinib
0.01
 76.02 771.67 4419 11106 0.3979 0.5740
MN20160304_L01
M14
MCF 10A-H2B-mCherry Trametinib
0.01
 78.25 771.67 3753 11367 0.3301 0.5032
MN20160304_L01
H06
MCF 10A-H2B-mCherry Trametinib
0.01
 78.25 771.67 4631 11367 0.4074 0.5869
MN20160304_L01
M14
MCF 10A-H2B-mCherry Trametinib
0.01
 80.48 771.67 3853 11685 0.3297 0.5071
MN20160304_L01
H06
MCF 10A-H2B-mCherry Trametinib
0.01
 80.48 771.67 4786 11685 0.4096 0.5928
MN20160304_L01
M14
MCF 10A-H2B-mCherry Trametinib
0.01
 82.69 771.67 3914 11974 0.3269 0.5075
MN20160304_L01
H06
MCF 10A-H2B-mCherry Trametinib
0.01
 82.69 771.67 4990 11974 0.4167 0.6030
MN20160304_L01
M14
MCF 10A-H2B-mCherry Trametinib
0.01
 84.92 771.67 3996 12266 0.3258 0.5100
MN20160304_L01
H06
MCF 10A-H2B-mCherry Trametinib
0.01
 84.92 771.67 5240 12266 0.4272 0.6161
MN20160304_L01
M14
MCF 10A-H2B-mCherry Trametinib
0.01
 87.14 771.67 4072 12592 0.3234 0.5112
MN20160304_L01
H06
MCF 10A-H2B-mCherry Trametinib
0.01
 87.14 771.67 5337 12592 0.4238 0.6162
MN20160304_L01
M14
MCF 10A-H2B-mCherry Trametinib
0.017783
 2.49 771.67 848 867 0.9772 0.7457
MN20160304_L01
D08
MCF 10A-H2B-mCherry Trametinib
0.017783
 2.49 771.67 816 867 0.9404 0.3909
MN20160304_L01
N22
MCF 10A-H2B-mCherry Trametinib
0.017783
 4.71 771.67 966 956 1.0101 1.0657
MN20160304_L01
D08
MCF 10A-H2B-mCherry Trametinib
0.017783
 4.71 771.67 936 956 0.9787 0.8656
MN20160304_L01
N22
MCF 10A-H2B-mCherry Trametinib
0.017783
 6.94 771.67 1041 1045 0.9961 0.9820
MN20160304_L01
D08
MCF 10A-H2B-mCherry Trametinib
0.017783
 6.94 771.67 1040 1045 0.9951 0.9777
MN20160304_L01
N22
MCF 10A-H2B-mCherry Trametinib
0.017783
 9.16 771.67 1130 1138 0.9925 0.9735
MN20160304_L01
D08
MCF 10A-H2B-mCherry Trametinib
0.017783
 9.16 771.67 1099 1138 0.9653 0.8780
MN20160304_L01
N22